Transcription
KNL1 mRNA expression is dominant in normal human testis and slight expression are observed in other organs, such as placenta. Analysis on cancer cell lines, such as HeLa, gave single band with 8.5 kb. There is another alternative splicing site at the 5' side of this gene that generates a short exon with 78 bp in cDNA. There are potential other alternative splicing at cancer cell lines. Analysis on testis mRNA shows two bands with size of approximately 6 and 8,5 kb which are probably derived from the two isoforms.
Protein

Description
Encodes 1833 amino acids and 2342 amino acids. The KLN1 protein contains: conserved motifs, which are the following: a (S/G)ILK motif (aa 25-28), a RRVSF motif (aa 57-61), and, for BUB3 recognition, MELT repeats (aa 140-161, 308-329, 474-494, 562-582, 750-769, 859-882, 902-924, 940-962, 1025 MELT repeats (aa 140-161, 308-329, 474-494, 562-582, 750-769, 859-882, 902-924, 940-962, -1044 MELT repeats (aa 140-161, 308-329, 474-494, 562-582, 750-769, 859-882, 902-924, 940-962, , 1073 MELT repeats (aa 140-161, 308-329, 474-494, 562-582, 750-769, 859-882, 902-924, 940-962, -1096 MELT repeats (aa 140-161, 308-329, 474-494, 562-582, 750-769, 859-882, 902-924, 940-962, , 1114 MELT repeats (aa 140-161, 308-329, 474-494, 562-582, 750-769, 859-882, 902-924, 940-962, -1136 MELT repeats (aa 140-161, 308-329, 474-494, 562-582, 750-769, 859-882, 902-924, 940-962, , 1152 MELT repeats (aa 140-161, 308-329, 474-494, 562-582, 750-769, 859-882, 902-924, 940-962, -1174 . The Bubs recognition KI motifs KI(D/N)XXXF(L/I)XXLK, are KIDTTSFLANLK (aa 202-213) for BUB1, and KIDFNDFIKRLK (aa 238-249) for BUB1B: (BUBR1); a nuclear localization signal (aa 1789-1803); a coiled coil region (aa 1942-2133) Recently, it suggested that there are two pathways for recruiting MAD1-MAD2 that results in SAC activation. One is the pathway through KBB, as described above, the other is KNTC1 (ROD)-RW10-ZWILCH, (RZZ) complex, which interacts with KNL1 through ZWINT (Zwint-1 protein). The former is required for SAC activation when kinetochores are misaligned but is not essential when kinetochores are unattached from microtubules. The latter binds SPDL1 (Spindly protein) and MAD1-MAD2, and causes the anaphase-onset delay in response to unattached kinetochore independently of the former. It was suggested that the binding of KNL1 with microtubules and with PP1 contribute to silencing of SAC, in which motor protein dynein, moving along on microtubules, is suggested to work to strip MAD1-MAD2. The C-terminal region of KNL1 interacts with MIS12 and Zwint-1 protein, through RWD motif and coiled-coiled region, respectively. The binding with the former plays role in connecting inner kinetochore with KNL1 and the latter mediates the interaction of KNL1 with RZZ complex which works in SAC regulation as described above.
Implicated in
Leukemia
A small subset of leukemia with a t(11;15)(q23;q14) has been described for long and has often be referred as: t(11;15)(q23;q15) MLL/AF15q14. KMT2A, (previous symbol: mixed leukemia gene (MLL)) is translocated with KNL1 (previous symbol CASC5, originally described as AF15q14), which makes research of published cases often arduous. t(11;15)(q23;q15) and/or KMT2A/KNL1 t(11;15)(q23;q14-15) Data on 16 cases with a t(11;15)(q23;q14-15), according to (Yang et al., 2014) are the following: there was 2 of myelodysplastic syndrome (MDS) cases, 10 acute myeloid leukemia (AML) cases (2 M1, 4 M2, 3 M4, and 1 NOS), and 4 acute lymphoblastic leukemia (ALL) cases. Mean age of the patients was 20.6 years (range 1-54); there were 11 males and 5 females. Abnormalities of chromosome 3 were seen in 10 out of 16 cases. Out of 8 patients for whom clinical data were available, only 3 are in complete remission, whereas 5 patients died with a mean survival period of 10.4 months. t(11;15)(q23;q15) and KMT2A/KNL1 Of 7 cases with a t(11;15)(q23;q15) and KMT2A/KNL1 hybrid gene and fusion protein ( (Chinwalla et al., 2003; Kuefer et al., 2003; Meyer et al., 2006; Yang et al., 2014) . Diagnosis was: therapy related MDS (t-MDS) in 2 cases, AML in 4 cases (1 M2, 2 AML-M4, 1 AML-NOS), and 1 de novo T-ALL. Sex ratio was 5M:1F; There was 3 children and 4 adult patients. Of three cases with data on survival, patients died at: 8 mths, 8 mths, and 22 mths. Of four cases with documented karyotypes: the karyotype was a complex karyotype with markers in two cases, abnormalities of chromosome 3 were seen in three cases, +21 in two cases. KMT2A (MLL) exon 8, 9, or 10 were fused to exon 10, 11 or 12 of KNL1, the fusion protein contains the 1362 or 1418 first aa from MLL with aa 1796, 1818 or 1819 from KNL1 (according to authors and/or VEGA). A t(3;15;p14;q15) KNL1/ ADAMTS9-AS2 is mentioned, without further data in the ChiTARS database (Gorohovski et al., 2016) as a chimeric EST (dbEST Id:12413828; accession BQ375909).
Lung cancer
In one study on primary lung cancer, KNL1 mRNA expression was observed in more than 40% of the cases, which is the highest among all the different types of cancers examined. The study also revealed KNL1 (cancer susceptibility candidate 5) Takimoto M, Huret JL Atlas Genet Cytogenet Oncol Haematol. 2017; 21(6) 203 that clinicopathological findings correlates with KNL1 expression. KNL1 mRNA expression is more frequent in the tumors with low differentiation than the ones with moderate and high differentiation. Further, the tumors derived from smoker express higher incidence of KNL1 mRNA than the ones from non-smoker.
Spermatogenesis
KNL1 mRNA was highly expressed in normal testis. As KNL1 protein expressions were observed in spermatogonia and spermatocytes in seminiferous tube of human testes, this protein may also play a role in cell division as a kinetochore protein in meiotic cells. It is noteworthy that KNL1 protein is also significantly expressed in pre-acrosome of spermatids, especially from its early stage, suggesting that KNL1 might be playing important role in the formation of acrosome, an essential organelle for fertilization. KNL1 expressions in testes of the patients with infertility were significantly lower than normal ones.
Microcephaly
Disease Autosomal recessive primary microcephaly (MCPH) is a very rare neuro-developmental disorder with brain size reduction, no structural malformation of the brain at birth, mild-to moderate mental retardation and absence of other neurological or somatic disease. There are 12 genetic loci responsible for MCPH, and it was suggested that one of the responsible genetic locus, MCPH4, resides on chromosome 15. Subsequently, the study on the patients with MCPH4 of consanguineous families in Morocco revealed that a homozygous missense mutation was observed in exon 18 of KNL1 gene. This point mutation caused skipping this exon in splicing reaction in the mRNA maturation of KNL1, suggesting that the affected nucleotide is a part of Exonic splicing enhancers. The mutation resulted in frame-shift and truncation of KNL1 protein.
As RWD repeats at near its carboxy terminus were deleted by this mutation, the truncated protein is no longer able to bind to Mis12, leading to the defected recruitment of KNL1 protein to kinetochore. One of the patients in the Morroco families has cryptorchidism in addition to microcephaly. The results of studies on MCH4 is a direct demonstration that KNL1 is essential to cell division in vivo.
